Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in Rats

• Ngā kaituhi matua: Caixia Yin (Author), Yuanyuan Deng (Author), Yuangui Liu (Author), Jianmei Gao (Author), Lingli Yan (Author), Qihai Gong (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2018-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Chronic cerebral hypoperfusion (CCH) is regarded as a high-risk factor for cognitive decline of vascular dementia (VD) as it is conducive to induce beta-amyloid (Aβ) aggregation. Icariside II (ICS II), a plant-derived flavonoid compound, has showed neuroprotective effect on animal models of Alzheime...